NCT05875493View on ClinicalTrials.gov

A Food Effect Study of JAB-21822 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 12, 2023

Primary Completion Date

June 14, 2023

Study Completion Date

June 14, 2023

Conditions
Food Effect in Healthy Participants
Interventions
DRUG

JAB-21822

2 discrete single doses

DRUG

JAB-21822

2 discrete single doses

Trial Locations (1)

100070

Beijing GoBroad Boren Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Allist Pharmaceuticals, Inc.

INDUSTRY

NCT05875493 - A Food Effect Study of JAB-21822 in Healthy Subjects | Biotech Hunter | Biotech Hunter